文献速递贫血与红细胞疾病

静脉铁剂:临床实践中对短期和长期风险的认识足够吗?

Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?
PubMed 文献 · Br J Haematol · 2020-11-20

本文综述静脉铁剂不同产品的差异、不良事件机制与频率,讨论低磷血症、感染风险及铁过载等潜在风险,并分析不同临床场景下的风险获益比与给药策略。

要点

  • 静脉铁剂对真性缺铁和功能性缺铁均有效,但不良事件文献存在不一致。
  • 低磷血症是易被忽视的不良事件,需关注其发生途径与频率。
  • 需权衡感染风险、铁过载等潜在风险与获益,个体化给药。

核心结论

  • 静脉铁剂是贫血治疗的重要组成部分,理解其短期和长期风险有助于更明智的治疗决策。

研究设计与样本

  • 本文为综述,汇总新旧文献讨论不同铁剂产品的差异、不良事件机制与频率及相关临床问题。

主要发现

  • 静脉铁剂对真性缺铁和铁限制性贫血(功能性缺铁)均有益。
  • 低磷血症是不易被识别的不良事件,综述讨论了其发生途径与频率。
  • 综述还审视了感染风险、巨噬细胞铁处理及静脉铁剂所致铁过载的潜在但尚未证实的风险。

临床怎么用

  • 在不同临床场景(包括妊娠和癌症)中应考虑风险获益比和静脉铁剂给药策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intravenous (IV) iron as a therapeutic agent is often administered but not always fully understood. The benefits of IV iron are well proven in many fields, particularly in nephrology. IV iron is beneficial not only for true iron deficiency but also for iron-restricted anaemia (functional iron deficiency). Yet, the literature on intravenous iron has many inconsistencies regarding its adverse effects. Over the last several years, newer forms of iron have been developed, leading to the more regular use of iron and in larger doses. This review will summarize some of the older and newer literature regarding the differences among iron products, including the mechanisms and frequency of their adverse events (AEs). The pathway and frequency of an underrecognized adverse event (hypophosphataemia) will be discussed. Recent insights on infection risk and iron handling by macrophages are examined. Potential but presently unproven risks of iron overload due to IV iron are discussed. The impact of these on the risk:benefit ratio and dosing of intravenous iron are considered in different clinical settings, including pregnancy and cancer. IV iron is an essential component of the therapy of anaemia and understanding these issues will enable more informed treatment decisions and knowledgeable use of these drugs.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Rund D. Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice? Br J Haematol. 2020. PMID: 33216989. doi:10.1111/bjh.17202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。